Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ambati

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
T-Cell Therapy: Options for Infectious DiseasesShreemanta K Parida, Thomas Poiret, Liu Zhenjiang, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Aperiodic neural dynamics define a novel signature of glioma-induced excitation-inhibition dysregulationYoussef E Sibih, Abraham O Dada, Emily E Cunningham, et al.
Journal of Neurosurgery. Spine|April 3, 2026
Differences in the rate of distal junctional problems between L3 and L4 pedicle subtraction osteotomyVardhaan S Ambati, Saman Shabani, Praveen V Mummaneni, et al.
Clinical Spine Surgery|April 21, 2025
Do Patients With High ASA Grades Benefit From CSM Surgery?: A Report From the Quality Outcomes DatabaseVardhaan S Ambati, Arati Patel, Abraham Dada, et al.
Journal of Neurosurgery. Spine|August 29, 2025
Five-year follow-up after minimally invasive transforaminal lumbar interbody fusion versus decompression alone for grade 1 spondylolisthesis: are there any differences in outcomes?Andrew K Chan, Vardhaan S Ambati, Pavan Upadhyayula, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2024
Corrigendum to "Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma": [Ann Oncol 35 (2024) 1039-1047]T M Kim, M Taszner, S Novelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2024
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphomaT M Kim, M Taszner, S Novelli, et al.
Journal of Neurosurgery. Spine|September 13, 2024
Do obese patients undergoing surgery for grade 1 spondylolisthesis have worse outcomes at 5 years' follow-up? A QOD studySamer G Zammar, Vardhaan S Ambati, Timothy J Yee, et al.
Neurosurgical Focus|May 1, 2026
What factors predict return to work after surgery for grade 1 lumbar spondylolisthesis? A 5-year Spine CORe™ analysis of QOD dataTimothy J Yee, Vardhaan S Ambati, Jay Kumar, et al.
Neurosurgical Focus|May 1, 2026
How much do patients benefit in quality of life after surgery for cervical spondylotic myelopathy? A Spine CORe™ analysis of QOD dataZachary Englander, Vardhaan S Ambati, Eunice Yang, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
T-Cell Therapy: Options for Infectious DiseasesShreemanta K Parida, Thomas Poiret, Liu Zhenjiang, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Aperiodic neural dynamics define a novel signature of glioma-induced excitation-inhibition dysregulationYoussef E Sibih, Abraham O Dada, Emily E Cunningham, et al.
Journal of Neurosurgery. Spine|April 3, 2026
Differences in the rate of distal junctional problems between L3 and L4 pedicle subtraction osteotomyVardhaan S Ambati, Saman Shabani, Praveen V Mummaneni, et al.
Clinical Spine Surgery|April 21, 2025
Do Patients With High ASA Grades Benefit From CSM Surgery?: A Report From the Quality Outcomes DatabaseVardhaan S Ambati, Arati Patel, Abraham Dada, et al.
Journal of Neurosurgery. Spine|August 29, 2025
Five-year follow-up after minimally invasive transforaminal lumbar interbody fusion versus decompression alone for grade 1 spondylolisthesis: are there any differences in outcomes?Andrew K Chan, Vardhaan S Ambati, Pavan Upadhyayula, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2024
Corrigendum to "Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma": [Ann Oncol 35 (2024) 1039-1047]T M Kim, M Taszner, S Novelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2024
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphomaT M Kim, M Taszner, S Novelli, et al.
Journal of Neurosurgery. Spine|September 13, 2024
Do obese patients undergoing surgery for grade 1 spondylolisthesis have worse outcomes at 5 years' follow-up? A QOD studySamer G Zammar, Vardhaan S Ambati, Timothy J Yee, et al.
Neurosurgical Focus|May 1, 2026
What factors predict return to work after surgery for grade 1 lumbar spondylolisthesis? A 5-year Spine CORe™ analysis of QOD dataTimothy J Yee, Vardhaan S Ambati, Jay Kumar, et al.
Neurosurgical Focus|May 1, 2026
How much do patients benefit in quality of life after surgery for cervical spondylotic myelopathy? A Spine CORe™ analysis of QOD dataZachary Englander, Vardhaan S Ambati, Eunice Yang, et al.
Pageof 4